IRIS
ROVIELLO, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.063
EU - Europa 20.878
AS - Asia 4.039
AF - Africa 138
SA - Sud America 97
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 22
Totale 50.278
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.983
GB - Regno Unito 5.998
IE - Irlanda 3.941
CN - Cina 2.672
UA - Ucraina 2.242
SE - Svezia 1.920
IT - Italia 1.681
RU - Federazione Russa 1.534
FR - Francia 1.272
DE - Germania 1.067
SG - Singapore 866
FI - Finlandia 639
ES - Italia 174
VN - Vietnam 155
BE - Belgio 117
CI - Costa d'Avorio 78
CA - Canada 71
IN - India 62
BR - Brasile 61
NL - Olanda 50
TR - Turchia 48
IR - Iran 43
RO - Romania 33
AU - Australia 32
HK - Hong Kong 27
MU - Mauritius 26
CZ - Repubblica Ceca 25
EG - Egitto 25
PT - Portogallo 25
PL - Polonia 24
JP - Giappone 23
EU - Europa 21
LT - Lituania 19
PH - Filippine 14
SA - Arabia Saudita 13
CL - Cile 12
GR - Grecia 11
KR - Corea 11
SI - Slovenia 11
BG - Bulgaria 10
KG - Kirghizistan 10
AZ - Azerbaigian 9
NZ - Nuova Zelanda 9
PK - Pakistan 9
AT - Austria 8
ID - Indonesia 8
IL - Israele 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
CH - Svizzera 7
EC - Ecuador 7
KZ - Kazakistan 7
LU - Lussemburgo 7
LV - Lettonia 7
AR - Argentina 6
DK - Danimarca 6
HU - Ungheria 6
MY - Malesia 6
RS - Serbia 6
TH - Thailandia 6
BD - Bangladesh 5
EE - Estonia 5
LK - Sri Lanka 5
MD - Moldavia 5
ET - Etiopia 4
HR - Croazia 4
MX - Messico 4
PE - Perù 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
CY - Cipro 3
IM - Isola di Man 3
IQ - Iraq 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
UY - Uruguay 3
BO - Bolivia 2
GE - Georgia 2
LC - Santa Lucia 2
MA - Marocco 2
PA - Panama 2
AP - ???statistics.table.value.countryCode.AP??? 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CM - Camerun 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
LI - Liechtenstein 1
MC - Monaco 1
MK - Macedonia 1
OM - Oman 1
SN - Senegal 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 50.277
Salva come PNG Salva come JPEG
Città #
Southend 5.610
Fairfield 3.928
Dublin 3.914
Chandler 2.048
Jacksonville 1.928
Ashburn 1.799
Woodbridge 1.759
Santa Clara 1.581
Wilmington 1.461
Seattle 1.426
Houston 1.363
Cambridge 1.282
Ann Arbor 966
Princeton 760
Nanjing 617
Singapore 612
Siena 503
Beijing 449
Boardman 300
San Mateo 297
Helsinki 262
New York 233
San Diego 210
Shanghai 202
Nanchang 196
Shenyang 168
Málaga 163
Moscow 153
Dong Ket 144
Hebei 118
Tianjin 117
Brussels 109
Florence 90
Menlo Park 87
Changsha 86
Jiaxing 85
Abidjan 78
Kunming 78
London 76
Düsseldorf 71
Norwalk 60
Dearborn 58
Jinan 57
Munich 56
Milan 53
Rome 51
Ningbo 50
Falls Church 49
Venezia 48
Zhengzhou 45
San Francisco 43
Toronto 42
Frankfurt am Main 41
Los Angeles 40
Guangzhou 38
Washington 38
Dallas 36
Hangzhou 35
Lappeenranta 33
Höst 28
Redwood City 28
Fremont 27
Port Louis 26
Izmir 25
Tappahannock 25
Taizhou 23
Lanzhou 22
Changchun 20
Kilburn 17
Hong Kong 16
Hounslow 16
Phoenix 16
Brno 15
Genoa 14
Leawood 14
Ottawa 14
Porto 14
Serra 14
Tokyo 14
Verona 14
Bologna 13
Sacramento 13
Andover 12
Newark 12
Piscataway 12
Riyadh 12
Amsterdam 11
Atlanta 11
Canberra 11
Chicago 11
Indiana 11
Melbourne 11
Viareggio 11
Zanjan 11
Bangalore 10
Berlin 10
Bishkek 10
Mestre 10
Tehran 10
Cairo 9
Totale 36.825
Salva come PNG Salva come JPEG
Nome #
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study 233
Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2 210
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) 210
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 208
C-Met targeting in advanced gastric cancer: An open challenge 205
354. KRAS mutation in gastric cancer- molecular, and clinico-pathological characteristic 198
Nipple-areola complex reconstruction techniques: A literature review 194
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases 193
Familial aggregation of gastric cancer with microsatellite instability** 190
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 187
65. Molecular surgery for gastric cancer-role of microsatellite instability in elderly patients 187
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 185
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 183
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 178
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 178
612. Molecular background of high risk and low risk areas of gastric cancer in Italy 178
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses 178
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 177
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 177
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 177
611. Gastric cancer patients with familial aggregation of gastric cancer and Lynch syndrome associated cancers with microsatellite instability 176
Recurrence after surgery in esophago-gastric junction adenocarcinoma: Current management and future perspectives 176
E-cadherin germline mutation carriers: clinical management and genetic implications 176
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives 176
613. Lymph node metastases in microsatellite unstable gastric cancer 175
Clinical evaluation of the Mannheim Prognostic Index in post-operative peritonitis: a prospective cohort study 175
610. Heterogeneity of new molecular gastric cancer classifications. Clinico-pathological characteristic 173
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. 172
353. PIK3CA mutation in gastric cancer and the role of different codon mutations in the new molecular division of that neoplasm 172
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer 171
From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model 171
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 170
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 169
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial 169
530. Minimally invasive surgery for the treatment of colo-rectal adenocarcinoma: Laparoscopic and robotic approach 169
Il ruolo della chemioipertermia nel carcinoma del colon-retto 168
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study 168
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer 167
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 166
The pattern of lymph node metastases in microsatellite unstable gastric cancer 165
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data 165
Trattamento chirurgico radicale di emangiopericitoma retroperitoneale recidivo: case report. 165
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an italian family 165
CA 19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions 164
Clinical impact of molecular classifications in gastric cancer 163
Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO) 162
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 162
Vitamin E serum levels and gastric cancer: results from a cohort of patients in Tuscany, Italy 161
Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection? 161
HERG1 channels regulate VEGF-A secretion in human gastric cancer: Clinicopathological correlations and therapeutical implications 161
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 160
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 160
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables 159
Hepatic metastases from gastric cancer: A surgical perspective 159
Gastric stump carcinoma after distal subtotal gastrectomy for early gastric cancer: Experience of 541 patients with long-term follow-up 159
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the “Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network” (SICO-CCN) multicentre collaborative study 158
Trans-pericardal Color Doppler Ultra Sound to Assess Blood Flow in the Visceral Branches during Type A Dissection Procedures Complicated with Mesenteric Malperfusion 157
E-cadherin and hereditary diffuse gastric cancer. 156
Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes 155
External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study 155
High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. 155
Complications after surgery for gastric cancer in patients aged 80 years and over 155
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 154
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience 154
Robotic single docking total colectomy for ulcerative colitis: First experience with a novel technique 154
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 154
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence 153
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 152
Elastofibroma dorsi: three cases of personal experience 151
Primary non-Hodgkin's breast lymphoma: surgical approach. 151
International consensus on a complications list after gastrectomy for cancer 151
Super-extended (D3) lymphadenectomy in advanced gastric cancer. 150
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 150
K-RAS mutation in gastric cancer and its link with microsatellite instability status 149
Age Related Co-Morbidities in Colorectal Cancer Patients: Surgical Problems and Prognostic Impact 149
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 149
A rare case of primary small bowel adenocarcinoma with intussusception. 148
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer 148
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 148
Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project 148
Western perspective and epidemiology of gastric cancer 148
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer 148
Robot-assisted laparoscopic gastrectomy for gastric cancer 148
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 147
A clinical case of duodenal gastrointestinal stromal tumor with a peculiarity in the surgical approach. 147
Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. 147
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer 147
High incidence of familial gastric cancer in Tuscany, a region in Italy. 146
null 146
Surgical treatment of gastric cancer in Latvia: results of centralized experience. 145
Cell proliferation, cell death and angiogenesis in early and advanced gastric cancer of intestinal type 145
Gastro-pleuro-pericardial fistula following combined radiation and chemotherapy for lung metastases from renal cell carcinoma: report of a case 145
Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations 145
Factors influencing survival after hepatectomy for metastases from gastric cancer 145
Evidence of tumor microsatellite instability in gastric cancer with familial aggregation 145
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer 144
Presacral ganglioneuroma: a case report and review of literature 144
An aggressive early gastric cancer: Kodama's PenA type 144
Accuracy of transrectal ultrasound after preoperative radiochemotherapy compared to computed tomography and magnetic resonance in locally advanced rectal cancer. 144
null 144
Totale 16.394
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.485
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.620 0 0 0 0 0 730 798 1.325 883 849 380 655
2020/20217.476 284 910 226 795 299 854 288 1.118 917 588 618 579
2021/20225.462 458 686 364 383 259 204 252 187 321 564 587 1.197
2022/20237.698 473 464 1.067 1.079 751 1.681 170 575 775 228 221 214
2023/20245.578 290 168 458 212 176 1.564 2.027 77 22 178 57 349
2024/20255.222 323 655 992 644 1.633 975 0 0 0 0 0 0
Totale 51.104